DAKLINZA daclatasvir (as dihydrochloride) 30 mg tablet blister, Bristol-Myers Squibb Australia Pty Ltd, CON-559
Product name
DAKLINZA daclatasvir (as dihydrochloride) 30 mg tablet blister
Sponsor name
Bristol-Myers Squibb Australia Pty Ltd
ARTG
222743
Consent start
Consent no.
CON-559
Standard
Subsections 9(3)(a) and 9(5) of Therapeutic Goods Order No. 91 - Standard for labels of prescription and related medicines.
Non-compliance with standard
The name of the medicine and the active ingredient are not expressed as a
cohesive unit and the name of the active ingredient is not displayed in a text
size of not less than 3.0 mm.
Therapeutic product type
Prescription medicines